| Autor: |
Pou Casellas C; Oncode Institute, Hubrecht Institute, Royal Dutch Academy of Science (KNAW) and University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.; Department of Nephrology and Hypertension, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Pleguezuelos-Manzano C; Oncode Institute, Hubrecht Institute, Royal Dutch Academy of Science (KNAW) and University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Rookmaaker MB; Department of Nephrology and Hypertension, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Verhaar MC; Department of Nephrology and Hypertension, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Clevers H; Oncode Institute, Hubrecht Institute, Royal Dutch Academy of Science (KNAW) and University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. h.clevers@hubrecht.eu.; Roche Pharmaceutical Research and Early Development, 4058, Basel, Switzerland. h.clevers@hubrecht.eu. |
